RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Clinical trials for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New transplant combo aims to outsmart relapsed leukemia
Disease control Not yet recruitingThis study looks at a stem cell transplant from a half-matched donor (haploidentical) combined with drugs to prevent the cancer from coming back. It includes 40 adults aged 18-65 with active AML that has returned or not responded to treatment. The goal is to see if this approach …
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
Engineered immune cells take aim at tough blood cancers
Disease control Not yet recruitingThis early study tests a new treatment using the body's own immune cells, called CAR-T cells, to fight certain blood cancers (like T-cell leukemia/lymphoma) that have returned or not responded to standard therapy. The study will enroll about 20 to 28 adults aged 18-85. The main g…
Matched conditions: RELAPSED/REFRACTORY ACUTE MYELOID LEUKEMIA
Phase: NA • Sponsor: Donghua Zhang • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC